...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    pths-img

    Pelthos Therapeutics Inc, Common Stock

    PTHS

    ASQ

    $20.3

    -$1.83

    (-8.27%)

    1D
    Sector: Healthcare

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $11.88M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     34.90K
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $4.5 L
    $38 H
    $20.3

    About Pelthos Therapeutics Inc, Common Stock

    Pelthos Therapeutics Inc., formerly Channel Therapeutics Corporation, is a biopharmaceutical company focused on commercializing therapeutic products for high unmet patient needs. The Company's lead product, ZELSUVMI (berdazimer) topical gel, 10.3%, is used in the treatment of molluscum contagiosum infections (molluscum) in adults and pediatric patients one year of age and older. ZELSUVMI is an FDA-designated novel drug, and a prescription medication approved for the treatment of molluscum that can be administered at home by parents, patients, and caregivers. The Company is also evaluating the path forward for its existing NaV 1.7 development programs for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. more

    Sector: Healthcare

    Returns

    Data is not properly formatted.

    Ratios

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    PTHS
    ROA (LTM) 0.00%
    ROE (LTM) 0.00%

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    PTHS
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.00
    P/B 0.00
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Pelthos Therapeutics Inc share price today?

    Pelthos Therapeutics Inc (PTHS) share price today is $20.3

    Can Indians buy Pelthos Therapeutics Inc shares?

    Yes, Indians can buy shares of Pelthos Therapeutics Inc (PTHS) on Vested. To buy Pelthos Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PTHS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Pelthos Therapeutics Inc be purchased?

    Yes, you can purchase fractional shares of Pelthos Therapeutics Inc (PTHS) via the Vested app. You can start investing in Pelthos Therapeutics Inc (PTHS) with a minimum investment of $1.

    How to invest in Pelthos Therapeutics Inc shares from India?

    You can invest in shares of Pelthos Therapeutics Inc (PTHS) via Vested in three simple steps:

    • Click on Sign Up or Invest in PTHS stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Pelthos Therapeutics Inc shares
    What is Pelthos Therapeutics Inc 52-week high and low stock price?

    The 52-week high price of Pelthos Therapeutics Inc (PTHS) is $38. The 52-week low price of Pelthos Therapeutics Inc (PTHS) is $4.5.

    What is Pelthos Therapeutics Inc price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Pelthos Therapeutics Inc (PTHS) is 0.00

    What is the Market Cap of Pelthos Therapeutics Inc?

    The market capitalization of Pelthos Therapeutics Inc (PTHS) is $11.88M

    What is Pelthos Therapeutics Inc’s stock symbol?

    The stock symbol (or ticker) of Pelthos Therapeutics Inc is PTHS

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top